Skip to content
Screener

Incyte INCY Operating Lease ROU Assets

Operating Lease ROU Assets at other companies

Celldex Therapeutics logo
Celldex TherapeuticsCLDX
$5.04M+61.4%
Geron logo
GeronGERN
$1.76M-30.1%
Protagonist Therapeutics logo
Protagonist TherapeuticsPTGX
$6.95M-19.1%
Syndax Pharmaceuticals logo
Syndax PharmaceuticalsSNDX
$1.21M-32.7%
Agios Pharmaceuticals logo
Agios PharmaceuticalsAGIO
5.7%0.0pp
Cogent Biosciences, Inc. logo
Cogent Biosciences, Inc.COGT
$17.55M-10.5%

Other financials

Income statement

See full
Revenue$1.7B+37.7%
Gross profit$1.6B+38.0%
Operating income$697.9M+31.6%
Net income$585.6M+44.6%
EPS (diluted)$2.81+37.7%

Balance sheet

See full
Cash & equivalents$4.0B+104%
Total debt$38.3M-9.8%
Total equity$6.3B+52.1%
Total assets$7.9B+35.2%

Cash flow

See full
Operating cash flow$507.7M+1,035%
CapEx$1.6M-43.5%
Free cash flow$509.3M+1,069%

Valuation

See full
Market cap$24B+58.2%
Enterprise value$20.05B+51.3%
P/E14.9×-2.5×
P/S4.1×+0.8×

Profitability

See full
Gross margin92.6%-0.3pp
Operating margin30.6%+4.8pp
Net margin27.7%+8.7pp
FCF margin34%+12.3pp

Returns & leverage

See full
Return on equity30.7%+6.4pp
Debt / equity0.0×
Current ratio4.6×+1.7×

Where this comes from

Reported directly by Incyte in its filing.

Tagged under the XBRL concept us-gaap:FinanceLeaseRightOfUseAsset.

The source filing: Incyte’s 10-Q, filed July 28, 2026.

Filed
Jul 28, 2026, 4:02 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0000879169-26-000056
Line itemJune 30,2026December 31,2025*
Long term equity investments104,38747,991
Inventory345,026342,232
Property and equipment, net709,469730,885
Finance lease right-of-use assets, net25,55927,520
Other intangible assets, net103,196117,131
Goodwill133,000133,000
Deferred income tax asset336,863515,294
Other assets, net86,75918,166

Item 1. Financial Statements

FAQ

What is Incyte's operating lease ROU assets?
Incyte (INCY) reported operating lease ROU assets of $25.56M in Q2 2026.
How has Incyte's operating lease ROU assets changed year-over-year?
Incyte's operating lease ROU assets decreased by 11.9% year-over-year, from $29M to $25.56M.
What is the long-term trend for Incyte's operating lease ROU assets?
Over 5 years (2020 to 2025), Incyte's operating lease ROU assets has grown at a -0.7% compound annual growth rate (CAGR), from $28.45M to $27.52M.
What does operating lease ROU assets mean?
Right-of-use assets representing the lessee's right to use leased property over the lease term under ASC 842 operating lease classification.

Ask your AI about Incyte's operating lease rou assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude